Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
NCT04933552
·
clinicaltrials.gov ↗
RECRUITING
Status
867
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
OTHER:
Siponimod
Sponsor
Novartis Pharmaceuticals